» Articles » PMID: 36694248

Levothyroxine Absorption Test Followed by Directly Observed Treatment on an Outpatient Basis to Address Long-term High Thyrotropin Levels in a Hypothyroid Patient: a Case Report

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2023 Jan 24
PMID 36694248
Authors
Affiliations
Soon will be listed here.
Abstract

Background: For the treatment of hypothyroidism, patients are usually placed on lifelong levothyroxine replacement therapy. Achieving clinical and biochemical euthyroid status is sometimes difficult because of several factors, including poor compliance or poor absorption of levothyroxine in the gut mucosa.

Case Presentation: We present the case of a 45-year-old South Asian female with hypothyroidism on lifelong levothyroxine replacement. However, on her multiple follow-up visits over the past 2 years, it was noted that her thyrotropin level was never controlled and was not in range. A thorough history was unyielding in terms of compliance regarding levothyroxine medication and use of over-the-counter pills or mineral supplements that may interfere with the absorption of levothyroxine. Hence, we performed levothyroxine absorption test to rule out any malabsorption as well as document pseudo-malabsorption favoring drug nonadherence. Levothyroxine absorption test resulted in more than 56% absorption of levothyroxine; therefore, the patient was put on weekly directly observed treatment strategy resulting in normalization of thyrotropin levels on successive follow-ups.

Conclusion: Directly observed treatment to replace levothyroxine once a week can be used as an alternative by health care professionals in patients in whom compliance to daily levothyroxine is the hidden cause of persistently raised thyrotropin. This strategy can reduce undue health burden on the patient and improve adherence to self-medication under confident supervision of the treating physician.

Citing Articles

Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With "Refractory Hypothyroidism".

Caron P, Tudor C, Grunenwald S J Endocr Soc. 2025; 9(4):bvaf017.

PMID: 40046102 PMC: 11879399. DOI: 10.1210/jendso/bvaf017.


Medication-Nonadherent Hypothyroidism Requiring Frequent Primary Care Visits to Achieve Euthyroidism.

Kaul S, Gupta A Fed Pract. 2024; 41(3):84-87.

PMID: 38835675 PMC: 11147436. DOI: 10.12788/fp.0461.

References
1.
Morris J . How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?. Clin Endocrinol (Oxf). 2009; 70(5):671-3. DOI: 10.1111/j.1365-2265.2009.03536.x. View

2.
Jonklaas J, Bianco A, Bauer A, Burman K, Cappola A, Celi F . Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014; 24(12):1670-751. PMC: 4267409. DOI: 10.1089/thy.2014.0028. View

3.
Yildirim Simsir I, Soyaltin U, Ozgen A . Levothyroxine absorption test results in patients with TSH elevation resistant to treatment. Endocrine. 2019; 64(1):118-121. DOI: 10.1007/s12020-019-01889-x. View

4.
Virili C, Antonelli A, Santaguida M, Benvenga S, Centanni M . Gastrointestinal Malabsorption of Thyroxine. Endocr Rev. 2018; 40(1):118-136. DOI: 10.1210/er.2018-00168. View

5.
Ghosh S, Pramanik S, Biswas K, Bhattacharjee K, Sarkar R, Chowdhury S . Levothyroxine Absorption Test to Differentiate Pseudomalabsorption from True Malabsorption. Eur Thyroid J. 2020; 9(1):19-24. PMC: 7024890. DOI: 10.1159/000504218. View